Antibodies for the treatment of ErbB-2 / ErbB-3 positive tumors

MDE20260408A1Pending Publication Date: 2026-06-30MERUS NV
0 Cites 0 Cited by

Patent Information

Application Number
MDE20260408T
Authority / Receiving Office
MD · MD
Patent Type
Applications
Current Assignee / Owner
Priority Date
2017-03-31
Filing Date
2018-04-03
Publication Date
2026-06-30
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.